To mark IDC Herzliya’s 20th anniversary, we spent a day following Prof. Uriel Reichman, IDC’s founder and president, and Jonathan Davis, VP for External Relations, around its delightful campus.
Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.
The rasagiline tablets, which are approved in over 40 countries for the treatment of Parkinson’s disease, gained UK and EU-marketing authorization in 2005 and US FDA approval in 2006.
“It is estimated there are about 150,000-180,000 people diagnosed with Parkinson’s disease in Japan, many of whom are waiting for a new treatment option,” said Nancy Joseph-Ridge, M.D., General Manager of Takeda’s Pharmaceutical Development Division located in Osaka, Japan in a press release on April 27.
“We will continue working on the development in cooperation with Teva so that we can bring this medicine to Japanese patients as quickly as possible,” Joseph-Ridge said.
“This agreement represents Teva’s continued commitment to introducing our innovative medicines to patients in Japan,” added Teva Global R&D president and Chief Scientific Officer, Dr. Michael Hayden.
Teva and Takeda entered an agreement in December 2013 to develop glatiramer acetate for the treatment of multiple sclerosis.
Developed by Teva, rasagiline was initially discovered by two Haifa Technion professors, John Finberg and Moussa Youdim, who were instrumental in the early clinical development of the anti-Parkinson drug.
Parkinson’s disease is a degenerative disorder of the central nervous system, whose symptoms include shaking, rigidity, slowness of movement and difficultly with walking as well as dementia in advanced stages. An estimated seven to 10 million people suffer from the disease across the world according to the Parkinson’s Disease Foundation.
According to Teva’s website, rasagiline is a monoaxmine oxidase B (MAO-B) inhibitor that increases available synaptic dopamine in the brain, which might improve the motor symptoms characteristic of Parkinson’s, slowing the progression of the disease.
“Rasagiline has an established safety and efficacy profile…[it] will be an important product for Japan, where the number of available treatment options for Parkinson’s disease remains limited,” said Dr. Hayden.
About the Author: Anav Silverman is a regular contributor to Tazpit News Agency.
If you don't see your comment after publishing it, refresh the page.
Comments are closed.
“Ninety percent of them [Arabs] don’t know what is written in the Kuran.”
“Lone wolves” trying to murder Jews are popping up too frequently.
The Gurlitt Museum promises all looted art will be returned to the rightful owners.
Israeli Shayetet 13 Naval commandos discovered a wounded fellow swimmer in the water, while they were doing a training exercise on Thursday morning. The commandos helped and treated the dolphin until a marine animal doctor could arrive to help it further. By the way, the temperature in Israel was between 52-66 degree Fahrenheit on Thursday, […]
A pre-Thanksgiving speech for Americans. Obama, are you listening?
Murderers have upgraded their weapons from rocks and firebombs to guns.
Thanksgiving is an American secular holiday that most Jews have no problem celebrating due to its lack of overt religious symbols (unlike the American holidays right before and after it). Still, there are always holdouts for some reason or another. Let’s hear what you do…
Maybe he thought those white hoods are prayer shawls although they are closer to being burkas.
As the expression goes, “Don’t bring a knife to a gunfight.”
Hamas snipers fired from Gaza at an IDF routine patrol operating along the security fence early afternoon on Thursday. No injuries were reported, and the vehicle was damaged. The IDF responded with an artillery shell aimed at the source of fire.
Jacob Richman found this amusing mistake in the store. Do we eat these “extra crispy” soap nuts, or wash the dishes with them?
For every terrorist cell Israel announces it has captured, there are many more kept under wraps.
On Monday evening, tTwo Arab MKs hurled epithets at MKs David Rotem and Feiglin from the podium. Here is Feiglin’s response.
Over 200 hair salons across Israel took part in the annual nationwide drive to collect hair for the Zichron Menachem Cancer Support in Israel in partnership with Pantene Products Israel.
But even with the cloud of sadness that descended on Jerusalem’s Har Nof neighborhood, as the community mourned the gruesome murders and the bloodied synagogue, there was a spark of happiness felt – in the synagogue itself.
Thousands attend slain rabbis’ funerals; international community condemns terror attack
Police documents reveal that Hezbollah has been providing the Brazilian gang with weapons while also acting as intermediaries in the sale of explosives that the PCC stole from Paraguay.
“We promised to take care of the residents of southern Israel and we are keeping that promise,” emphasized Minister of the Economy, Naftali Bennett.
War of Words Between Bibi and Obama Drives Out Turnout of US Citizens in Israel
Printed from: http://www.jewishpress.com/news/breaking-news/tevas-parkinson-drug-now-marketed-in-japan/2014/05/29/
Scan this QR code to visit this page online: